INTRODUCTION
Proliferating cancer cells exhibit an increased dependence on biosynthetic intermediates (Vander Heiden and DeBerardinis, 2017) , including fatty acids (FAs) that support the construction of organelle and plasma membranes. To meet the demand for elevated FA levels, FA synthase (FASN) overexpression is commonly observed in multiple cancers (Menendez and Lupu, 2007; Ricoult et al., 2016) . Palmitate, the product of FASN enzymatic activity, can be further modified by elongation and desaturation, where double bonds between carbon atoms are introduced into long-chain FAs. Stearoyl-coenzyme A (CoA) desaturase (SCD), the principal enzyme responsible for desaturation, is critical for sustained viability of a variety of tumor cell types (Igal, 2016) . By introducing a double bond into the saturated FA stearate, SCD produces monounsaturated oleate, typically the most abundant intracellular FA. Although clearly important for cell survival, activity of the oxygen (O 2 )-dependent SCD enzyme can be constrained by tumor hypoxia ( Figure 1A ). Periods of O 2 starvation, therefore, lead to a buildup of saturated FA precursors, causing disruption of endoplasmic reticulum (ER) membranes and apoptosis Young et al., 2013) . Saturated FA-induced toxicity can be alleviated by supplying exogenous unsaturated lipids (for instance, by increasing the availability of serum FAs), indicating that lipid uptake is an important mechanism for maintaining homeostasis in hypoxic cancer cells (Young et al., 2013) .
Accentuated accumulation of neutral lipids in large lipid droplets (LDs) is observed in a subset of tumor types, particularly clear cell renal cell carcinoma (ccRCC). In ccRCC, this phenotype has been linked to genetic loss of the von Hippel-Lindau (VHL) tumor suppressor, which causes constitutive hypoxia inducible factor-a (HIFa) stabilization regardless of O 2 availability. We have previously shown that induction of HIF2a specifically promotes lipid accumulation through upregulation of PLIN2, the gene encoding the LD coat protein perilipin-2 (Qiu et al., 2015) . PLIN2 loss significantly represses tumor growth, indicating that LD formation may be driven by HIF2a stabilization and serves a cytoprotective role in ccRCC. In a separate study, HIF-dependent repression of FA b-oxidation has also been demonstrated to contribute to LD accumulation (Du et al., 2017) .
LDs are primarily composed of cholesterol esters (CEs) and triglycerides (TGs), and lipidomic analyses of ccRCC samples revealed high levels of both in tumors compared with normal kidney (Saito et al., 2016; Sundelin et al., 2012) . TGs consist of a glycerol backbone and three FAs ( Figure 1E ), with a significant diversity in FA chain length and number of double bonds. Their synthesis requires the activity of the diglyceride acyltransferase (DGAT) enzymes DGAT1 and DGAT2, which catalyze the condensation of fatty acyl-CoA with a diglyceride (DG) to form TG. The two human DGAT enzymes share no homology and have dissimilar expression patterns (Yen et al., 2008) . TGs are synthesized in the ER, but DGAT2 can also be found on the surface of LDs and may generate TGs in growing LDs in situ (Wilfling et al., 2013) . To mobilize lipid stores to provide FAs, TGs are broken down by a series of lipases, and the released FAs can, in principle, be used for incorporation into other lipid types, such as phospholipids (PLs), or for mitochondrial oxidation. Although the protective function of LDs and TG turnover have been identified in a number of contexts (Bailey et al., 2015; Bensaad et al., 2014) , the full scope of TG synthesis and catabolism in tumor cells remains unclear.
Here we evaluated the consequences of limiting TG synthesis in ccRCC. We found that concurrent inhibition of DGAT1 and DGAT2 severely compromised in vivo tumor growth because of increased cell death. This was replicated in cultured cells exposed to low O 2 and serum, mimicking a stressful tumor microenvironment. Mechanistically, TGs sequester exogenous unsaturated FAs, particularly oleate, when in ample supply. When oleate availability becomes limiting during O 2 and serum deprivation, however, oleate is instead released into other lipid pools. This prevents the buildup of fully saturated, toxic lipids in cellular compartments outside of LDs. Our work reveals a dynamic mechanism by which TGs act as buffers for cellular lipid homeostasis, especially under the tumor-relevant conditions of O 2 and nutrient limitation.
RESULTS AND DISCUSSION

Disruption of TG Synthesis Compromises ccRCC Tumor Growth
Although the functional roles of CEs in cancer have been interrogated to some extent (Yue et al., 2014) , TGs have so far remained considerably less well studied. We investigated how direct disruption of TG synthesis by loss of DGAT enzymes affects lipid homeostasis. DGATs appear to carry out mutually redundant functions in the storage of both endogenously synthesized and exogenously derived FAs ( Figure 1A ). We confirmed their redundancy in A498 ccRCC cells by examining the induction of neutral lipid stores upon administration of oleic acid conjugated with BSA versus BSA alone. Although a combination of CRISPR/ Cas9-mediated DGAT2 deletion and DGAT1 pharmacological inhibition fully abrogated this, loss of neither DGAT individually was sufficient ( Figure S1A ). This approach provides the opportunity to precisely control the timing of DGAT inhibition by adding the DGAT1 inhibitor T863 (DGAT1i) to cells with DGAT2 deletion. Importantly, DGAT deficiency was complemented with a CRISPR-resistant DGAT2 cDNA, restoring neutral lipid deposition ( Figure S1A ). To study the consequences of TG synthesis inhibition in vivo (and employ a complementary approach), we generated A498 cells expressing both DGAT1 and DGAT2 short hairpin RNAs (shRNAs) under the control of a Tet-inducible promoter and confirmed that these constructs effectively reduce DGAT mRNA and protein levels upon doxycycline treatment (Figures S1B and S1C). After implanting these cells subcutaneously in immunocompromised recipients and allowing tumors to grow to an average size of 300 mm 3 , mice were fed with either control or doxycycline-containing chow. A substantial reduction in both DGAT1 and DGAT2 transcript levels ( Figure S1D ) and significantly reduced tumor volume and weight was observed ( Figures 1B and 1C) . Immunohistochemical staining of tumor sections revealed increased numbers of apoptotic cells based on cleaved caspase-3 staining and decreased numbers of actively dividing Ki67+ cells ( Figure 1D ). As anticipated, TG levels were lower in DGAT-deficient tumors compared with controls ( Figure 1E ; Table S1 ), although the observed differences failed to reach statistical significance. These results likely reflect the inherent heterogeneity between cells within solid tumors with regard to TG synthesis and turnover, in addition to variable O 2 and nutrient availability. Nevertheless, a pronounced increase in TGs containing one or more saturated FAs (R1 saturated FAs [SFAs]; Figure 1F ), but not those exclusively carrying unsaturated FAs (0 SFAs; Figure 1F ) was observed. Thus, DGAT silencing disrupts TG FA composition and causes both increased apoptosis and reduced proliferation of ccRCC tumor cells in vivo.
DGAT Loss Compromises ccRCC Viability in Low O 2 and Serum
We next sought to establish exactly how TG metabolism promotes tumor growth. Because solid tumors are notoriously poorly perfused and hypoxic (Frantz et al., 2010) , we specifically focused on how serum lipid and O 2 limitation results in DGAT dependency. Of note, combined serum and O 2 limitation led to deteriorated cell viability upon DGAT knockdown (Figure 2A ). Because hypoxia limits SCD activity ( Figure S2A ) and reduces cell viability in the absence of exogenous lipid supply Qiu et al., 2015) , we investigated whether enhanced sensitivity of DGAT-deficient cells to these conditions is indeed mediated by reduced SCD function. Cells were exposed to the SCD inhibitor CAY10566, which phenocopied the effect of O 2 deprivation ( Figure 2B ).
To understand the relationship between serum levels and TG metabolism, a lipidomic comparison of A498 cells cultured in either high (5%) or low (0.5%) serum-containing medium was performed, revealing substantial remodeling of the intracellular lipid composition. Among the most pronounced changes were significant reductions in CEs as well as in TGs ( Figure 2C ). Limiting serum in vitro led to large decreases in the abundance of unsaturated TGs ( Figure 2C ) and a shift toward TG saturation ( Figure 2D ), as noted for solid tumors ( Figures 1E and 1F) . A striking depletion in neutral lipid stores was also confirmed by borondipyrromethene (BODIPY) imaging ( Figure S2B ), in line with earlier observations (Bensaad et al., 2014) . This indicates that, in addition to HIF signaling, availability of exogenous serum lipids is critical for maintaining abundant lipid stores. Increased TG storage observed under hypoxia appears to be cytoprotective and renders cells more resistant to subsequent hypoxia and hypoxia-reoxygenation-mediated cytotoxicity (Bensaad et al., 2014) . Moreover, TGs may also harbor polyunsaturated FAs to protect them against peroxidation (Bailey et al., 2015) . To establish whether lipid stores ''buffer'' against lipid saturation in our system, we determined whether any one class of lipid preferentially ''absorbs'' alterations in FA saturation under hypoxia. Strikingly, TG composition was affected much more profoundly than other lipid classes (Figures 2E and S2C) , including a loss of TGs harboring unsaturated FAs and a shift toward increased TG saturation ( Figure S2D ). Moreover, these changes were only observed under low-serum conditions. When A498 cells were exposed to pharmacological SCD inhibition instead of hypoxia ( Figure S2E ), we observed a similar but more pronounced increase in TG saturation ( Figure 2F ) as well as a stronger effect on other lipid classes (especially DGs), the direct precursors for TGs. This difference is most likely due to a combination of more potent SCD inhibition by pharmacological approaches compared with hypoxia (leading to increased FA saturation) as well as a limited capacity of TGs to cope with the increased FA saturation, leading to ''spill-over'' into other lipid classes. Importantly, when other ccRCC cell lines (786-O and UMRC2) were exposed to low O 2 , FA saturation was similarly most pronounced in TGs, followed by the direct precursor DGs (Figures S2F and S2G) . This suggests that TGs have a capacity to promote cell viability by balancing the availability of specific FAs.
Serum deprivation reduced intracellular TG abundance (Figure 2G) , in keeping with the BODIPY imaging depicted in Figure S2B . As demonstrated with in vivo tumor growth (Figures 1E and 1F) , DGAT silencing in vitro also caused a further decrease in TG abundance ( Figure 2G ) and selective depletion of unsaturated TGs ( Figure 2H ). Given that both hypoxia and DGAT depletion cause increased saturation of the TG pool under low-serum conditions, we asked whether combination of the two leads to a cumulative effect; i.e., an even more saturated TG pool. Indeed, in the setting of low serum availability, O 2 deprivation or pharmacological SCD inhibition increased TG saturation (Figures 2I and 2J) . Again, more potent pharmacological SCD inhibition (compared with hypoxia) resulted in increased TG saturation relative to O 2 starvation. Additional DGAT knockdown further lowered TG levels ( Figure 2G ), resulting in an even more saturated TG pool (Figures 2I and 2J) . These results highlight a protective role of LDs under serum-and O 2 -limited conditions through buffering cellular FA saturation.
TGs Neutralize Excess Fatty Acid Saturation through Release of Stored Oleate
Although the aforementioned protective role of TGs could simply be due to their ability to sequester excess saturated FAs into TGs, TG synthesis by DGAT enzymes is more efficient when the substrates are unsaturated rather than saturated (Listenberger et al., 2003) . LDs could alternatively protect cells by preferentially releasing unsaturated FAs from stored TGs for use in the production of cytosolic and membrane-associated lipids. Because monounsaturated oleate (C18:1) is the single most abundant FA in TG pools ( Figure S3A ), its mobilization during periods of unsaturated lipid deprivation should ameliorate stress by preventing the synthesis of fully saturated, potentially toxic lipids. A498 cells experiencing stringent conditions of low serum and pharmacological SCD inhibition exhibited reduced total TG levels ( Figure 3A ), supporting this hypothesis. To further test this, we assessed the protective potential of oleate, which is efficiently incorporated into TGs and, consequently, the most abundant TG FA. A498 cells were pre-treated with oleate under low-serum conditions before being exposed to SCD inhibition. Oleate pre-treatment indeed promoted cell viability under these conditions ( Figure 3B ), which was largely abolished upon DGAT silencing, suggesting that it occurs through TGs.
To study the cellular fate of oleate in more detail, we designed a washout labeling approach ( Figure 3C ; see STAR Methods for information about lipid tracing). Serum-starved and, hence, LDdepleted A498 cells were first exposed to labeled [U 13 C]-oleate in the ''loading'' phase. We employed cells with DGAT2 loss induced through CRISPR/Cas9-mediated mutagenesis (Figure S1A) Figure 3D ; data not shown). As expected, DGAT inhibition severely limited the incorporation of labeled oleate into TGs. Based on our data, we reasoned that, under conditions of saturated FA excess, TG oleate mobilization and subsequent re-esterification into other lipid classes enables continued production of lipids with at least one unsaturated FA, preventing Figure 3F ). In accordance with total TG levels (Figure 3A) and BODIPY imaging ( Figure 3E ), cells loaded with labeled oleate (0 hr, ÀDGAT1i) exhibited a strong reduction in TG FA labeling over the course of the washout (48 hr). Cells treated with DGAT1i during loading had lower labeled FA levels to start, which were almost entirely depleted during washout ( Figure 3F ). Analysis of DG, PC, and PE lipids indicated that [U
13
C 18 ] mono-unsaturated FAs (MUFAs) were incorporated into all three classes during loading. Because the exogenous [U
C]-oleate tracer was removed at the start of washout, we expected levels of labeled FAs in these lipids (as for TGs) to diminish because of continuous turnover. This was evidently the case for the DGAT1i-treated cells because at least a 2-fold reduction in labeling was observed. Strikingly, this reduction was not detected in untreated cells, most likely because oleate originally loaded in the TG pool is subsequently feeding into DG, PC, and PE lipid pools during washout. By reducing the TG pool, DGAT inhibition prevents the subsequent flow of oleate from TGs to other lipid classes during periods of unsaturated lipid deprivation Adipose triglyceride lipase (ATGL) and monoacylglycerol lipase (MAGL) have been shown previously to play supportive roles in cancer progression (Nomura et al., 2010; Zagani et al., 2015) , suggesting that mobilization of TG stores is critical for tumor cell metabolism. We investigated the outcome of pharmacological inhibition of TG hydrolysis ( Figure S3B ) and did not observe appreciable effects of disrupting ATGL or MAGL activity on the flow of labeled oleate from TG into other lipid types (see STAR Methods for experimental details). In contrast, inhibition of hormone-sensitive lipase (HSL) led to accumulation of labeled DG, in accordance with its ascribed function as a DG lipase (Figure S3B) . HSL inhibition also substantially reduced the washout of TG labeling and caused more abundant PC labeling than in untreated cells. The effects of HSL inhibition were confirmed in two additional ccRCC cell lines ( Figure S3C ), consistent with DG's role as a substrate for PL synthesis. Of note, in 786-O cells, almost no labeled FAs were left in the TG pool at the end of the washout experiment, suggesting that the FA buffering capacity in this cell line is somewhat more limited. This is consistent with the more pronounced saturation of the DG pool upon cellular stress ( Figure S2F ) and our observation that these cells have lower LD numbers under our conditions (data not shown). Our findings demonstrate that oleate (and, to a lesser degree, its elongated C20:1 product) can be released from the TG pool to feed into other lipid classes and most likely requires HSL to break down DGs produced by TG hydrolysis.
Based on our extensive labeling studies of TG turnover under different growth conditions, we propose that TGs act as a buffer for unsaturated FA (mostly oleate; Figure 3D ) availability (Figure 3G) . During exposure to high serum lipid and/or oleate levels, cells store large amounts of oleate in TGs via DGAT activity. When transitioning to a low-serum environment, TG pools shrink because of HSL-mediated hydrolysis, and released oleate replenishes other lipid species. This helps maintain a viable FA composition when cells are additionally experiencing excess FA saturation, as occurs during tumor hypoxia.
Compromised FA Buffering by TGs Causes Diversion of Saturated FAs into Toxic Ceramides and Acyl-carnitines Because ceramides are predominantly generated from saturated FAs, and excess buildup promotes apoptosis, we investigated their abundance following DGAT inhibition. DGAT depletion resulted in a large increase in ceramide levels in A498 cells treated with SCD inhibitor under serum-deprived conditions ( Figure 4A ) and A498 xenograft tumors ( Figure 4B ), along with acyl-ceramides ( Figure 4C ). Acyl-carnitines have recently been shown to be elevated upon DGAT inhibition, contributing to mitochondrial dysfunction (Nguyen et al., 2017) . In line with this, we observed elevated acyl-carnitine upon DGAT knockdown in the context of in vitro hypoxia ( Figure 4D ), in vitro SCD inhibition ( Figure 4E ), and in vivo xenograft tumors ( Figure 4F ). These changes indicate that disrupted TG synthesis widely affects lipid homeostasis and accumulation of toxic lipid species.
To further evaluate the effects of decreased cellular lipid homeostasis through DGAT loss, we performed both in vivo and in vitro microarray studies. A498 tumor samples harboring DGAT shRNA were compared with controls, and a gene set enrichment analysis (GSEA) was performed ( Figure 4G) . A parallel analysis of A498 cells grown under 0.5% serum and exposed to either 21% O 2 or 0.5% O 2 for 48 hr, with or without induction of DGAT shRNA expression, was also performed ( Figures S4A and S4B ). The expression of transcriptional targets of nuclear factor kB (NF-kB) exhibited a striking pattern of regulation that suggests induction by lipid dysregulation. In vivo, DGAT depletion led to a significant increase in NF-kB target gene expression ( Figure 4G ). In vitro, the same gene set was enriched by hypoxia, DGAT loss, and the combination of these two treatments under serum deprivation (Figures S4A-S4C ). Of note, we observed a stepwise increase in many NF-kB target gene mRNAs by sequentially combining DGAT loss and hypoxia ( Figure S4D ). NF-kB is known to be engaged under conditions of stress and excess saturated FA exposure (Van Beek et al., 2012; Carluccio et al., 1999; Massaro et al., 2002) , regulating desaturase activity and ovarian cancer stem cell identity (Li et al., 2017) . We therefore hypothesized that the elevated lipid saturation detected in DGAT-depleted tumors engages the NF-kB pathway. Using a luciferase reporter, we confirmed that both basal and tumor necrosis factor a (TNF-a)-induced NF-kB activity was enhanced by DGAT loss in A498 cells ( Figure 4H ). Importantly, NF-kB pathway (G) Model of the metabolic mechanism by which TGs alleviate the saturation of certain lipid classes (e.g., PCs) under conditions of unsaturated lipid deprivation by releasing stored oleate. Data are means of triplicate wells confirmed in independent experiments (A, B, and D) or means of three independent experiments each conducted in triplicate (F); error bars represent SD. Statistical significance by t test or ANOVA, as appropriate. *p < 0.05, **p < 0.05, and ***p < 0.005. See also Figure S3 . engagement was inhibited by the specific NF-kB inhibitor PS-1145 ( Figure 4H ) as well as the proteasome inhibitor ixazomib. Of note, ixazomib inhibits NF-kB by stabilizing its negative regulator inhibitor of kB (IkB) (Mujtaba and Dou, 2011) . Serum deprivation also led to increased NF-kB reporter activity, which was fully inhibited by administration of both PS-1145 and ixazomib ( Figure 4I ). Collectively, our data suggest that DGAT deficiency leads to broad disruption of lipid homeostasis, resulting in unsaturated FA depletion and accumulation of saturated FAs and, consequently, ceramides, acyl-ceramides, and acyl-carnitines ( Figure 4J ). This is accompanied by activation of NF-kB signaling, previously documented to respond to increased saturated FAs. Future work will delineate whether NF-kB signaling contributes to balancing FA availability during stressful conditions as a prosurvival mechanism.
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Altered TG Saturation in ccRCC Patient Samples
Given the requirement for DGAT activity to survive conditions of excess lipid saturation in our experiments, we determined whether this is a common feature of human tumor biology. We therefore re-analyzed published data comparing the TG composition of ccRCC patient samples and normal kidney tissues (Saito et al., 2016) . As expected, TG levels were strongly elevated in ccRCC, as documented previously (Sundelin et al., 2012) . However, the fold change was particularly pronounced for TGs containing one or more SFAs, demonstrating an increase in TG saturation ( Figure 4K ). This increase in ccRCC TG saturation is consistent with TG regulation of FA composition in lipid pools, as observed in our in vitro experimental system ( Figures  3E and 3F ). We therefore suggest that increased FA saturation (and its buffering by TGs) occurs in tumor samples derived from ccRCC patients.
Conclusion
Although oncogenic signaling alters cellular metabolism to promote the synthesis of macromolecules, malignant cells are also programmed to withstand nutrient scarcity (Boroughs and DeBerardinis, 2015) . This metabolic flexibility can involve the induction of scavenging pathways, such as autophagy in RAS-or BRAF-driven cells (Yang et al., 2011) or macropinocytosis in KRAS-driven cells deprived of glutamine (Commisso et al., 2013) . Both KRAS and hypoxia promote the uptake of extracellular unsaturated lipids with similar consequences: cells become more resistant to O 2 deprivation and its associated inhibition of FA desaturases . Here, in the case of LDs, hydrolysis of unsaturated TGs supplies unsaturated DGs and FAs as substrates for PL synthesis, maintaining lipid homeostasis during periods of increased FA saturation. We therefore propose that unsaturated FA storage in TGs contributes to ccRCC metabolic plasticity and that its inhibition may effectively target cancer cells residing in ischemic tumor domains ( Figure 4J ).
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: (Saito et al., 2016) were reanalyzed to investigate shifts in TG saturation. TG species were binned according to the number of fully saturated FA chains present, and the abundance of each category was aggregated and is displayed as a ratio of the abundance in normal tissue. For (A), (D), (E), data are means of 5 and for (H) and (I) of 3 replicate wells, and results were confirmed in independent experiments. For (B), (C), (F), and (G), data are means of tumors from 4 tumors. Error bars represent SD. Statistical significance by t test or ANOVA, as appropriate. *p < 0.05, **p < 0.05, and ***p < 0.005. See also Figure S4 . 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
Subcutaneous xenograft experiments were approved by the Animal Care and Use Committee at the University of Pennsylvania. 10 Female NIH-III nude mice (Charles River; 4-6 weeks old) were injected subcutaneously in both flanks. The injection mix contained 5 million cells in PBS, mixed 1:1 with Matrigel Basement Membrane Matrix (Corning). Tumor volume was monitored by caliper measurements. After tumors reached 300 mm3, mice were split into cohorts of 5 mice receiving doxycycline chow (200 mg/kg; Harlan Labs) or control chow (Harlan Labs) ad libitum. After experiment completion, animals were sacrificed by CO2 inhalation, and xenograft tumors were dissected for downstream analyses.
Cell Lines and cell culture conditions Authenticated (short tandem repeat profiling) human cell lines HK-2, 786-O, 769-P, A498, RCC4, RCC10, UOK101, and UMRC2 were obtained from the American Type Culture Collection. Cell lines were routinely passaged in DMEM (GIBCO) with 25 mM glucose and 2 mM L-glutamine with 5% (v/v) fetal bovine serum (FBS, GIBCO) at 37 C and 5% CO 2 . Cells were split at 80% confluency. All cell lines described in this study were verified mycoplasma-negative. Experiments were performed in DMEM supplemented with 10 mM glucose, 2 mM L-glutamine and indicated levels of FBS (Sigma). Hypoxic conditions were maintained at 0.5% O 2 , 37 C and 5% CO 2 in the InVivO 2 Hypoxia Workstation with a Ruskinn Gas mixer Q (Baker Co.). Cell number was assessed using the Countess Cell Counter (ThermoFisher) or estimated using packed cell volume (PCV, Sartorius Volupac), as appropriate. dFBS). Cells were incubated for 48h in these conditions followed by lipid extraction as described in Lipid extraction and liquid chromatography -mass spectrometry (LC-MS) analysis, below. The tracing experiment was repeated three times independently with each condition conducted in triplicate.
qRT-PCR studies Total RNA was isolated using the RNAeasy purification kit (QIAGEN). cDNA was synthesized using the Applied Biosystems High Capacity RNA-to-cDNA master mix. qRT-PCR was performed on a ViiA7 Real Time PCR systems from Applied Biosystems. Predesigned Taqman primers were obtained from Life Technologies for the following genes: TBP (HS01060665_G1), ACTB (HS01060665_G1), DGAT1 (HS01017541_M1), and DGAT2 (HS01045913_M1).
DGAT mutant and knockdown lines DGAT1 and DGAT2 shRNA (specified as DGAT shRNA unless stated otherwise) was achieved by expressing Dox-inducible shDGAT2_5 (TRCN0000005195) using the Tet-pLKO-puro plasmid and shDGAT1_1 (TRCN0000036151) using the Tet-pLKO-neo. Lentivirus was generated for each plasmid in HEK293T cells and used to infect the relevant cell line. After selection with puromycin and G418, the knockdown of both DGAT1 and DGAT2 transcripts was confirmed by qRT-PCR (Taqman probes; ThermoFisher) DGAT2 knockout cell lines were generated by cloning sgRNA sequences 5 0 -TGTGCTCTACTTCACTTGGC-3 0 and 5 0 -GTACATGAG GATGGCACTGC-3 0 into the lentiviral vector lentiCrisprv2 (Addgene), generating lentivirus in HEK293T cells and transducing ccRCC cell lines with 25ml of un-concentrated supernatant. After puromycin selection, single cell clones were generated by limiting dilutions in 96 well plates. Single-cell clones were expanded and genomic DNA was isolated from a portion of the expanded cell population. PCR of the DGAT2 locus was performed using DA182 (TCCTCTTGTCCCAGGAATCTGC) forward and DA184 CACTCAGGAT GAGGCCCTTCAG reverse primers. PCR products were TOPO-cloned using the Zero Blunt PCR cloning kit (ThermoFisher) and transformed into competent E. coli. For each clone, 3-6 colonies were picked and grown overnight in LB-Ampicillin. Plasmid DNA was isolated using the QiaPrep Miniprep kit (QIAGEN) and sequenced using a nested primer DA183 (GAATCTGCTCC TACCTGGGCTG). Clones containing mutations in both alleles were tested phenotypically by Bodipy neutral lipid staining, and LC/MS confirmed reduced TG production (data not shown), as expected. Cells were incubated with 1:50 dilution of oleic acid-BSA mix (Sigma; 2 mole OA/mole albumin; 100mg/ml albumin) for 16h with and without the presence of 2 mM DGAT1i (T863, Sigma). Clonal lines with full loss of DGAT2 activity loss had complete abrogation of neutral lipid storage by oleic acid stimulation when DGAT1 was inhibited. Rescue of DGAT2 loss was performed by cloning DGAT2 cDNA from the pcDNA3.1 vector (GeneCopoeia) into the pCDH lentiviral expression plasmid pCDH-CMV-MCS-EF1-Neo using the primers DA199 (GTTTCTgctag cATGAAGACCCTCATAGCCGC), DA200 (GTTTCTgcggccgcTCAATGGTGATGGTGATGATG) as well as DA199 and DA201 (gtttctGCGGCCGCtcaGTTCACCTCCAGGACCTCAG) for expression with and without V5 and Histags. gRNA sites were then mutated to prevent cutting by Cas9 protein expressed in the mutant cell lines. Synonymous mutations were introduced using DA187 (TACTGGGAGTGGCaTGCAGTGCCAT) and DA188 (ATGGCACTGCAtGCCACTCCCAGTA).
Flow cytometry assays
For experiments, cells were seeded in 6-well plates 24 hours before the experiment at a cell density that led to 80% confluency at the end of the experiment. BODIPY 493/503 (Cat D3922) was purchased from Life Technologies and FITC-Annexin V, PI Kit (cat. 556547) from BD Biosciences. Live cells were washed twice in PBS and incubated in 2 mg/ml BODIPY in PBS for 15 minutes at 37 C. After staining, cells were washed twice in PBS and re-suspended in Annexin-V binding buffer (BD Cat 556454), passed through a cell strainer, and analyzed on an Accuri C6 flow cytometer. For viability assays, cells were stained with FITC-Annexin V and PI according to the manufacturer's instructions and double-negative cells were deemed viable. Median signal intensity for each well was average for triplicate samples to determine staining intensity.
Lipid droplet imaging
Cells were seeded on round glass coverslips of 24-well plates and supplemented with 1 mL of medium and exposed to the indicated conditions. The medium was then aspirated, cells washed once with 1 mL room temperature PBS, fixed with 0.5 mL of 4% formaldehyde (Sigma) for 30 min after which excess was removed and cells washed 3x with 1 mL PBS. Cells then were incubated with 0.3mL of 1 mM BODIPY 493/503 (Life Technologies) (excitation wavelength 480nm, emission maximum 515 nm) for 15 min in the dark, washed 2x with 1 mL PBS, incubated with 0.3 mL of 1 mg/mL DAPI (Sigma) for 15 min in the dark and washed 2x with 1 mL PBS. Thereafter, the coverslips were mounted on glass slides using Dako Fluorescent Mounting Medium (Dako). Z stack images were acquired using Olympus FV1000 confocal laser scanning microscope (405 nm laser for DAPI and 488 nm laser for BODIPY) and processed with ImageJ software.
Lipid extraction and liquid chromatography -mass spectrometry (LC-MS) analysis
For cultured cells the medium was aspirated and cells washed 2x with 1 mL room temperature PBS. The cells were placed on ice and quenched with 0.75 mL of methanol/PBS (1:1, v/v) at À20 C, and kept for 10 min. The cells were then scraped into glass tubes (Fisher Scientific), 0.5 mL chloroform at À20 C (Sigma) and 50 mL of 1 mg/mL methanolic butylated hydroxytoluene (BHT, Sigma) added, followed by addition of SPLASH lipidomix internal standard mix (Avanti Polar Lipids) at 1 mL per 1*10 5 cells. This was vortexed for 1 min and centrifuged at 500g for 10 min. The chloroform layer was transferred to a new glass vial, dried under nitrogen gas and stored at À20 C for further LC-MS analysis. Samples were reconstituted in chloroform/methanol (1:1 v/v) at 50 mL per 1*10 5 cells prior to the LC-MS analysis. For extraction of tumor tissues, 10-35 mg was transferred to ice-cold Precellys lysing tubes, 0.75 mL of methanol/PBS (1:1, v/v) at À20
C and 50 mL of 1 mg/mL BHT in methanol added, and homogenized using pre-cooled Precellys Tissue Homogenizer at À10
C. The homogenization program included 3 cycles of 30 s of shacking at 5,000 rpm and 15 s pause per cycle. Further sample treatment was as for cultured cells, with addition of 0.5 mL chloroform at À20 C and internal standard mix at 10 mL per 10 mg tissue. Samples were reconstituted at a concentration of 200 mL per 10 mg of tissue in chloroform/methanol (1:1 v/v) prior to the LC-MS analysis.
Lipidomic analysis was performed using a Q Exactive orbitrap mass spectrometer coupled to a Dionex UltiMate 3000 LC system (Thermo Scientific). The LC parameters were as follows: 4 mL of sample was injected onto a 1.7 mm particle 100 3 2.1mm ID Waters Acquity CSH C18 column (Waters) which was kept at 50 C. A gradient of (A) water/acetonitrile (40:60, v/v) with 10 mM ammonium formate and (B) acetonitrile/2-propanol (10:90, v/v) with 10 mM ammonium formate at a flow rate of 0.3 mL/min was used. The gradient ran from 0% to 40% B over 6 min, then from 40% to 100% B in the next 24 min, followed by 100% B for 4 min, and then returned to 0% B in 2 min where it was kept for 4 min (40 min total). Lipids were analyzed in both positive and negative mode. The electrospray and mass spec settings were as follows: spray voltage 3 kV (positive mode) and 3.5 kV (negative mode), capillary temperature 300 C, sheath gas flow 50 (arbitrary units), auxiliary gas flow 7 (arbitrary units) and sweep gas flow 5 (arbitrary units). The mass spec analysis was performed in a full MS and data dependent MS 2 (Top 10) mode, with a full scan range of 300-1200 m/z, resolution 70,000, automatic gain control at 1x10 6 and a maximum injection time of 250 ms. MS 2 parameters were: resolution 17,500, automatic gain control was set at 1x10 5 with a maximum injection time of 120ms.
Lipase inhibitor assays A498, 786-O or UMRC2 cells were grown in 0.5% serum (low serum) for 24h, then loaded with 10 mM U-13C oleate for 24h incubation under low serum. Labeled oleate was washed out by growing cells under low serum for 48h with or without addition of a lipase inhibitor. ATGL inhibitor atglistatin (Sigma SML1075) was used at 50 mM, HSL inhibitor CAY10499 (Cayman chemicals) was used at 50 mM and MAGL inhibitor JJKK048 (Tocris) was used at 50 mM. Cells were then counted and harvested for lipidomic analysis.
Microarray experiments
For in vivo analysis of gene expression following inducible DGAT knockdown, mice bearing 300mm3 tumors from subcutaneously injected A498 DGAT shRNA cells were fed either doxycycline-or control-chow for 5 days. The animals were then sacrificed, the tumors harvested and RNA was extracted using the RNEasy kit (QIAGEN). RNA was then deposited with the University of Pennsylvania Molecular Profiling core facility for processing, microarray analysis using the Affymetrix HTA 2.0 Chip and analysis.
Suitability of using 13 C-labeled FAs to study lipid metabolism FAs supplied to cells can be used for oxidation to generate energy, can directly be incorporated into lipids, or can first be further matured (i.e., elongated, desaturated) prior to lipid assembly. Oxidation of 13 C-labeled FAs leads to generation of 13 C-acetylCoA, which in turn can be used for the synthesis of new FAs. This would lead to complex labeling distributions that would complicate interpretation of labeling patterns and hence lipid metabolic events. To determine the feasibility of using 13 C-FAs to study lipid metabolism, A498 cells were incubated for 6 hours with 25 mM [U 13 C]-stearate (C18:0) and labeling of triglycerides was assessed (Figure S5A ). This short time span was sufficient to generate extensively labeled TGs. Notably, after correcting for natural 13 C occurrence, the majority of TG isotopologs observed were the unlabeled (M 0 ), the M +18 isotope corresponding to the incorporation of one [U 13 C]-C18:0, as well as M +36 and M +54 that result from the incorporation of 2 and 3 labeled FAs, respectively. Some minor odd-labeled isotopes (M +19 , M +37 , M +55 ) were observed; these are most likely caused by imperfect corrections for 13 C-natural abundance by the algorithm. Importantly, no significant partial labeling was observed, demonstrating that FA synthesis from 13 C-acetyl-CoA due to FA oxidation is not detectable and does not complicate FA tracing experiments.
Fragmentation spectra of labeled TGs further confirmed that labeled FAs shorter than 18 carbons do not occur. This is arguably best demonstrated by the MS 2 pattern of TG(48:0) M +18 (one labeled FA, Figure S5B Figure S5C ). We therefore concluded that tracing with 13 C-labeled FAs is suitable for investigating the dynamics of lipid metabolism.
QUANTIFICATION AND STATISTICAL ANALYSIS
Lipidomic data processing Peak detection, peak area quantification, lipid identification, and alignment were performed using LipidSearch (Thermo Fisher Scientific/Mitsui Knowledge Industries) with standard settings for Q Exactive Product Search. Data was then exported to Excel and lipid peak areas were normalized to the peak area of the corresponding lipid internal standard using an in-house R script. The normalized peak areas of identified lipids were used for plotting. Volcano plots were generated using ggplot2 R package by plotting log Fold change (n = 5 for each condition) against -log P value (Wickham, 2009 ). Significant changes with R 1.5-fold and p % 0.05 are indicated in color according to the figure legend.
Saturation indices for different lipid classes are represented as a ratio of total palmitate and stearate to oleate. The total level of palmitate in individual lipid class was calculated by summing up the intensities of each palmitate-containing lipid multiplied by the number of palmitate moieties in each lipid (i.e., total palmitate in TG = S (1*TG(16:0/18:0/18:1) + 2*TG(16:0/16:0/18:1) +3*TG(16:0/ 16:0/16:0))). The same principle was used for calculation of total stearate and oleate.
For stable isotope tracing experiments MAVEN software was used. A total 13 C-FA incorporation value for each lipid class was calculated by summing up the labeling intensities for those lipids of that class that were most intensely labeled and together contained R 80% of total label. A labeling intensity per lipid was calculated by summing up the intensities for each labeled isotope multiplied by the number of labeled FAs for that particular isotope (i.e., total labeling = S (1*M+18 + 2*M+36 +3*M+54)).
Statistical Analysis
For bar plot, the height of the bar represents the mean of all replicates and error bars represent ± SD or ± SEM, as indicated in the Figure 
DATA AND SOFTWARE AVAILABILITY
The A498 DGAT shRNA in vivo microarray experiment and the A498 DGAT shRNA in vitro microarray experiment data were deposited at NCBI GEO (https://www.ncbi.nlm.nih.gov/geo/) under accession numbers GEO: GSE117774 and GSE117775 respectively.
